These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27788881)

  • 1. Slow desensitization of imatinib-induced nonimmediate reactions and dynamic changes of drug-specific CD4
    Klaewsongkram J; Thantiworasit P; Sodsai P; Buranapraditkun S; Mongkolpathumrat P
    Ann Allergy Asthma Immunol; 2016 Nov; 117(5):514-519. PubMed ID: 27788881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization to imatinib in patients with leukemia.
    Nelson RP; Cornetta K; Ward KE; Ramanuja S; Fausel C; Cripe LD
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):216-22. PubMed ID: 16937754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib-induced ulcerative colitis.
    Ma Z; Zhao J; Li S; Gao F; Zhang C; Wu L; Lin Y
    J Oncol Pharm Pract; 2024 Sep; 30(6):1111-1117. PubMed ID: 38772691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.
    Farag S; Verschoor AJ; Bosma JW; Gelderblom H; Kerst JM; Sleijfer S; Steeghs N
    J Clin Pharmacol; 2015 Aug; 55(8):920-5. PubMed ID: 25810235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A successful approach to overcome imatinib-induced skin toxicity in a GIST patient.
    Desar IM; van Herpen CM; van Erp NP; Kaal SE; van de Kerkhof PC; van der Graaf WT
    Anticancer Drugs; 2016 Jul; 27(6):576-9. PubMed ID: 26982239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
    Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H
    Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications.
    Park SR; Ryu MH; Ryoo BY; Beck MY; Lee IS; Choi MJ; Lee MW; Kang YK
    Cancer Res Treat; 2016 Jan; 48(1):162-70. PubMed ID: 26323636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumor.
    Bar-Sela G; Kedem E; Hadad S; Pollack S; Haim N; Atrash F; Shahar E
    Jpn J Clin Oncol; 2010 Feb; 40(2):163-5. PubMed ID: 19797416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperpigmentation due to imatinib: A rare case of cutaneous involvement.
    Rehman H; Hakim N; Sugarman R; Seetharamu N; Saif MW
    J Oncol Pharm Pract; 2020 Sep; 26(6):1511-1515. PubMed ID: 32067560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Drug and Possible New Toxicity - Squamous Cell Carcinoma Following Imatinib in Patients with Gastrointestinal Stromal Tumors.
    Inayat F; Saif MW
    Anticancer Res; 2016 Nov; 36(11):6201-6204. PubMed ID: 27793952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis.
    Wilde B; Dolff S; Cai X; Specker C; Becker J; Tötsch M; Costabel U; Dürig J; Kribben A; Tervaert JW; Schmid KW; Witzke O
    Nephrol Dial Transplant; 2009 Jan; 24(1):161-71. PubMed ID: 18723571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of T cells in nonimmediate allergic drug reactions.
    Rozieres A; Vocanson M; Saïd BB; Nosbaum A; Nicolas JF
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):305-10. PubMed ID: 19474707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.
    Nolte-'t Hoen EN; Wagenaar-Hilbers JP; Boot EP; Lin CH; Arkesteijn GJ; van Eden W; Taams LS; Wauben MH
    Eur J Immunol; 2004 Nov; 34(11):3016-27. PubMed ID: 15376196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
    Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
    Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib Mesylate Induced Erythroderma.
    Lunge S; Bhise R
    J Assoc Physicians India; 2018 Dec; 66(12):79-80. PubMed ID: 31313559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.
    Musolino C; Allegra A; Mannucci C; Russo S; Alonci A; Maisano V; Calapai G; Gangemi S
    Turk J Haematol; 2015 Jun; 32(2):168-71. PubMed ID: 26316486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
    Keung EZ; Fairweather M; Raut CP
    Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long induction of tolerance to imatinib.
    Bojanini L; Attia S; Heagney H; Gonzalez-Estrada A
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Steroid Treatment for Imatinib-Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study.
    Kim EJ; Ryu MH; Park SR; Beck MY; Lee WJ; Lee MW; Kang YK
    Oncologist; 2020 Nov; 25(11):e1785-e1793. PubMed ID: 32589310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up.
    Dervis E; Ayer M; Akin Belli A; Barut SG
    Eur J Dermatol; 2016 Apr; 26(2):133-7. PubMed ID: 26679005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.